Please login to the form below

Not currently logged in
Email:
Password:

commercialisation

This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.

Parexel launches medical writing solutions business

Parexel launches medical writing solutions business

drug development and commercialisation process. ... story through each stage of development and commercialisation.

Latest news

More from news
Approximately 0 fully matching, plus 506 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    CPPs, which establish the status of a pharmaceutical in the exporting country, are required by importing countries to ensure the product being registered or renewed aligns with the scope of commercialisation

  • Deal Watch January 2018

    Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits.

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    On the other hand, Align Biopharma is tackling long-standing challenges in the commercialisation of drugs and treatments, and how HCPs engage with life science companies.

  • Flight path: the long-haul journey Flight path: the long-haul journey

    But we don’t always get it right. In the past, pharma has been guilty of developing clinical programmes simply to get a product licence - focusing purely on commercialisation and profit

  • Breakthrough innovation Breakthrough innovation

    development. However, given the highly innovative, or breakthrough, nature of these products and services, agile approaches are better suited to achieve development and commercialisation success.

More from intelligence
Approximately 1 fully matching, plus 103 partially matching documents found.

Latest appointments

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona.

  • Zelluna Immunotherapy appoints chief technology officer Zelluna Immunotherapy appoints chief technology officer

    He will play a big part in the execution of Zelluna’s manufacturing strategy for clinical trials and commercialisation.”.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Jim’s extensive experience in driving excellence across R&D, commercialisation, manufacturing, business development and capital formation will be invaluable as we continue to build a genomic medicine leader and develop

  • Therachon poaches Shire’s Aled Williams Therachon poaches Shire’s Aled Williams

    There he was responsible for the commercialisation and development of Gattex/Revestive (teduglutide) for short bowel syndrome.

  • Lynn Lewis joins Envigo Lynn Lewis joins Envigo

    For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.

More from appointments
Approximately 0 fully matching, plus 116 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 27 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics